H. Ropers, A novel x-linked recessive mental retardation syndrome comprising macrocephaly and ciliary dysfunction is allelic to oral-facial-digital type i syndrome Disponible sur http, Hum Genet, vol.120, issue.2, pp.171-179, 2006.

A. Bush, R. Chodhari, N. Collins, F. Copeland, P. Hall et al., Primary ciliary dyskinesia: current state of the art, Archives of Disease in Childhood, vol.92, issue.12, pp.921136-921176, 2007.
DOI : 10.1136/adc.2006.096958

A. Clement, . Tamalet, . Leroux, . Ravilly, J. Fauroux et al., Long term effects of azithromycin in patients with cystic fibrosis : A double blind, placebo controlled trial Disponible sur http, Thorax, issue.10, pp.61895-902057950, 2005.

M. Cohen-cymberknoh, N. Simanovsky, N. Hiller, A. G. Hillel, D. Shoseyov et al., Differences in Disease Expression Between Primary Ciliary Dyskinesia and Cystic Fibrosis With and Without Pancreatic Insufficiency, Chest, vol.145, issue.4, pp.738-744, 2014.
DOI : 10.1378/chest.13-1162

M. Corey, H. Edwards, M. Levison, and . Knowles, Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis, The Journal of Pediatrics, vol.131, issue.6, pp.809-823, 1997.
DOI : 10.1016/S0022-3476(97)70025-8

G. Döring and N. Hoiby, Early intervention and prevention of lung disease in cystic fibrosis: a European consensus, Journal of Cystic Fibrosis, vol.3, issue.2, pp.67-91, 2004.
DOI : 10.1016/j.jcf.2004.03.008

A. Ellerman and H. Bisgaard, Longitudinal study of lung function in a cohort of primary ciliary dyskinesia, European Respiratory Journal, vol.10, issue.10, pp.2376-2379, 1997.
DOI : 10.1183/09031936.97.10102376

I. Equi, . Balfour-lynn, M. Bush, and . Rosenthal, Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial, The Lancet, vol.360, issue.9338, pp.360978-84, 2002.
DOI : 10.1016/S0140-6736(02)11081-6

F. Hildebrandt, T. Benzing, and N. Katsanis, Disponible sur http, Ciliopathies. N Engl J Med, vol.364, issue.16, pp.1533-1576, 2011.

J. Samantha, A. Irving, G. Ives, J. Davies, . Donovan et al., Lung Clearance Index and High-Resolution Computed Tomography Scores in Primary Ciliary Dyskinesia, American Journal of Respiratory and Critical Care Medicine, vol.188, issue.5, pp.545-549, 2013.

. Govan and . Webb, Clinical outcome for cystic fibrosis patients infected with transmissible pseudomonas aeruginosa : an 8-year prospective study Disponible sur http, Chest, vol.137, issue.6, pp.1405-909, 2010.

M. Kennedy, M. Omran, . Leigh, . Dell, P. Morgan et al., Congenital Heart Disease and Other Heterotaxic Defects in a Large Cohort of Patients With Primary Ciliary Dyskinesia, Circulation, vol.115, issue.22, pp.1152814-2821, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.649038

H. Olesen and E. Group, Factors associated with fev1 decline in cystic fibrosis : analysis of the ecfs patient registry

S. Kharitonov, P. Alving, and . Barnes, Exhaled and nasal nitric oxide measurements : recommendations. the european respiratory society task force

E. A. Gee, O. Halbritter, S. Kohl, M. Kircher, J. Krischer et al., Mutations in RSPH1 Cause Primary Ciliary Dyskinesia with a Unique Clinical and Ciliary Phenotype, American Journal of Respiratory and Critical Care Medicine, issue.6, pp.189707-717, 2014.

W. Michael, . Konstan, S. Jeffrey, . Wagener, R. Donald et al., Risk factors for rate of decline in fev1 in adults with cystic fibrosis Disponible sur http, J Cyst Fibros, vol.11, issue.5, pp.405-416, 2012.

M. Kurkowiak, M. Zietkiewicz, and . Witt, Recent advances in primary ciliary dyskinesia genetics, Journal of Medical Genetics, vol.69, issue.(Suppl 3), pp.1-10, 2014.
DOI : 10.1136/jmedgenet-2014-102755

C. Simon, A. R. Hewer, and . Smyth, Antibiotic strategies for eradicating pseudomonas aeruginosa in people with cystic fibrosis Disponible sur http, Cochrane Database Syst Rev, vol.11, issue.CD004197, 2014.

Z. Li, D. B. Sanders, J. Michael, . Rock, R. Michael et al., Regional differences in the evolution of lung disease in children with cystic fibrosis, Pediatric Pulmonology, vol.28, issue.7, pp.635-675, 2012.
DOI : 10.1002/ppul.21604

G. Theodore, . Liou, P. Eric, . Elkin, J. David et al., Year-to-year changes in lung function in individuals with cystic fibrosis Disponible sur http, J Cyst Fibros, vol.9, issue.4, pp.250-256, 2010.

V. Lund and D. Kennedy, Staging for rhinosinusitis. Otolaryngology-Head and Neck Surgery, pp.35-40, 1997.

J. Lundberg, S. Weitzberg, . Nordvall, J. Kuylenstierna, K. Lundberg et al., Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome, European Respiratory Journal, vol.7, issue.8, pp.1501-1505, 1994.
DOI : 10.1183/09031936.94.07081501

L. Máiz, M. Rosa, C. Girón, E. Olveira, A. Quintana et al., infection in cystic fibrosis: systematic review of randomised controlled trials, Expert Opinion on Pharmacotherapy, vol.25, issue.5, pp.1135-1184, 2013.
DOI : 10.1016/j.jcf.2012.10.004

K. June, N. Marthin, . Petersen, T. Lene, . Skovgaard et al., Lung Function in Patients with Primary Ciliary Dyskinesia, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.11, pp.1262-1268, 2010.

M. Angel-martínez-garcía, J. Soler-cataluña, M. Perpiñá-tordera, P. Román-sánchez, and J. Soriano, Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis, Chest, vol.132, issue.5, pp.1565-72, 2007.
DOI : 10.1378/chest.07-0490

P. Mccomb, . Langley, P. Villalon, and . Verdugo, The oviductal cilia and Kartagener???s syndrome**Presented at the Fortieth Annual Meeting of The American Fertility Society, New Orleans, April 2 to 7, 1984., Fertility and Sterility, vol.46, issue.3, pp.412-418, 1986.
DOI : 10.1016/S0015-0282(16)49578-6

J. Peter, . Mogayzel, . Jr, T. Edward, . Naureckas et al., Bruce C Marshall, and Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee Cystic fibrosis foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial pseudomonas aeruginosa infection Disponible sur http, pp.1640-50201404, 2014.

A. Moore, . Escudier, . Roger, . Tamalet, . Pelosse et al., RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa, Journal of Medical Genetics, vol.43, issue.4, pp.326-359, 2006.
DOI : 10.1136/jmg.2005.034868

M. Nicotra, M. Rivera, . Dale, R. Shepherd, and . Carter, Clinical, Pathophysiologic, and Microbiologic Characterization of Bronchiectasis in an Aging Cohort, Chest, vol.108, issue.4, pp.955-961, 2007.
DOI : 10.1378/chest.108.4.955

R. Pellegrino, . Viegi, R. Brusasco, . Crapo, . Burgos et al., Interpretative strategies for lung function tests, European Respiratory Journal, vol.26, issue.5, pp.948-68, 2005.
DOI : 10.1183/09031936.05.00035205

M. Pifferi, . Bush, . Di-cicco, . Pradal, . Ragazzo et al., Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia, European Respiratory Journal, vol.35, issue.4, pp.787-794, 2010.
DOI : 10.1183/09031936.00051509

M. Pifferi, . Bush, . Pioggia, . Caramella, D. Tartarisco et al., Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia, Thorax, vol.67, issue.11, pp.993-999, 2012.
DOI : 10.1136/thoraxjnl-2011-200137

M. Pifferi, M. D. Cicco, M. Piras, M. Angela, G. Cangiotti et al., Up to date on primary ciliary dyskinesia in children, Early Human Development, vol.89, issue.S3, pp.45-48, 2013.
DOI : 10.1016/j.earlhumdev.2013.07.022

T. Pressler, C. Bohmova, . Conway, . Dumcius, . Hjelte et al., Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report, Journal of Cystic Fibrosis, vol.10, issue.211, pp.75-83, 2011.
DOI : 10.1016/S1569-1993(11)60011-8

C. Que, D. Cullinan, and . Geddes, Improving rate of decline of FEV1 in young adults with cystic fibrosis, Thorax, vol.61, issue.2, pp.155-7043372, 2005.
DOI : 10.1136/thx.2005.043372

D. Reiff, . Wells, P. J. Carr, D. Cole, and . Hansell, CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types., American Journal of Roentgenology, vol.165, issue.2, pp.261-268, 1995.
DOI : 10.2214/ajr.165.2.7618537

B. Daniel, K. Rosenbluth, T. Wilson, . Ferkol, P. Daniel et al., Lung function decline in cystic fibrosis patients and timing for lung transplantation referral Disponible sur http, Chest, vol.126, issue.2, pp.412-421, 2004.

L. Jane, . Burns, C. Bruce, F. Marshall, A. Ratjen et al., Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with pseudomonas aeruginosa : a randomized controlled trial

L. Saiman, C. Bruce, N. Marshall, J. L. Mayer-hamblett, A. L. Burns et al., Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa, JAMA, vol.290, issue.13, pp.2901749-56, 2003.
DOI : 10.1001/jama.290.13.1749

F. Santamaria, H. Montella, . Tiddens, . Guidi, . Casotti et al., Structural and Functional Lung Disease in Primary Ciliary Dyskinesia, Chest, vol.134, issue.2, p.351, 2008.
DOI : 10.1378/chest.07-2812

C. Alice, B. Chen, S. Brain, S. Biga, P. Schlebusch et al., Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis : the bless randomized controlled trial, JAMA, vol.309, issue.12, pp.1260-1267, 2013.

J. Ulrich-sommer, K. Schäfer, H. Omran, H. Olbrich, J. Wallmeier et al., ENT manifestations in patients with primary ciliary dyskinesia: prevalence and significance of otorhinolaryngologic co-morbidities, European Archives of Oto-Rhino-Laryngology, vol.42, issue.3, pp.383-391, 2011.
DOI : 10.1007/s00405-010-1341-9

P. Tappenden, . Harnan, . Uttley, . Mildred, A. Carroll et al., Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model, Health Technology Assessment, vol.17, issue.56, pp.1-181, 2013.
DOI : 10.3310/hta17560

D. Taylor-robinson, M. Whitehead, F. Diderichsen, H. Vebert-olesen, T. Pressler et al., 194* Understanding the natural progression in FEV1 decline in patients with cystic fibrosis, Journal of Cystic Fibrosis, vol.10, issue.10, pp.67860-67866, 2012.
DOI : 10.1016/S1569-1993(11)60210-5

J. Torgersen, Transposition of Viscera - Bronchiectasis and Nasal Polyps: A Genetical Analysis and a Contribution to the Problem of Constitution, Acta Radiologica, vol.28, issue.1, pp.17-24, 1947.
DOI : 10.1177/028418514702800103

C. Vallet, E. Escudier, F. Roudot-thoraval, S. Blanchon, B. Fauroux et al., Primary ciliary dyskinesia presentation in 60 children according to ciliary ultrastructure, European Journal of Pediatrics, vol.7, issue.3
DOI : 10.1007/s00431-013-1996-5

D. Rhonda, . Vandyke, L. Gary, B. Mcphail, . Huang et al., Inhaled tobramycin effectively reduces fev1 decline in cystic fibrosis. an instrumental variables analysis Disponible sur http, pp.205-12201209, 2013.

F. Verra, M. Fleury-feith, M. Boucherat, . Pinchon, E. Bignon et al., Do Nasal Ciliary Changes Reflect Bronchial Changes?: An Ultrastructural Study, American Review of Respiratory Disease, vol.147, issue.4, pp.908-921, 1993.
DOI : 10.1164/ajrccm/147.4.908

. Vlm, Registre français de la mucoviscidose-bilan des données 2012 Disponible sur http, 2014.

C. Werner, J. G. Onnebrink, and H. Omran, Diagnosis and management of primary ciliary dyskinesia. Cilia Disponible sur http, pp.13630-13644, 2015.

T. Wodehouse, S. Kharitonov, I. Mackay, P. J. Barnes, P. Wilson et al., Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia, European Respiratory Journal, vol.21, issue.1, pp.43-47, 2003.
DOI : 10.1183/09031936.03.00305503

C. Wong, L. Jayaram, N. Karalus, T. Eaton, C. Tong et al., Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial, The Lancet, vol.380, issue.9842, pp.380660-380667, 2012.
DOI : 10.1016/S0140-6736(12)60953-2

F. Xu, Efficacy and safety of long-term inhaled antibiotic for patients with non-cystic fibrosis bronchiectasis : a meta-analysis, Clin Respir J, 2015.